RxDoctor Payments Data

Sakkapol Ongwijitwat, MD

Adult Reconstructive Orthopaedic Surgery · Indianapolis, INNPI 1356547095

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (38.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Encore Medical, LP at 44.6% of the total. Reporting peaked in 2024 at $15,118 and has fallen 90.1% since, to $1,494 in 2025.

$25,287in general payments, 2019–2025

Across 153 payments — averaging $165.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$11K
  • Zimmer Biomet$9K
  • Medacta USA, Inc.$1K
  • Smith+Nephew$773
  • Stryker$676
  • Johnson & Johnson$522
  • plus $2K from 15 others

What the payments were for

  • Consulting fees$9,60038%
  • Travel & lodging$7,22029%
  • Food & beverage$8,35333%
  • Gifts$1140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Indianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$282,357
Medicare patients
429
Services billed
13,187

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Varenicline Tartrate59$11,968
Celecoxib457$7,910
Methocarbamol99$1,015
Diclofenac Sodium48$845
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen87$770
Meloxicam225$501
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen41$352
Tizanidine Hcl22$322
Cephalexin92$312
Bupropion Hcl SrBupropion Hcl16$167
Amoxicillin212$153
Tramadol Hcl50$144
Clindamycin Hcl19$67
Cyclobenzaprine Hcl12$36

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →